TCG Crossover Management, LLC
Q3 2025 13F Holdings
- Locationpalo alto, CA
- Num holdings
40
- Value ($000)
$2,032,902
- Date Filed11/17/2025
- Form type13F-HR
- CIK0001839948
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ABIVAX SA AMERICAN DEPOSITARY SHARES | ADRS | 00370M103 | $603.77 M | 30 % | 7,111,596 | ||
CGON CG ONCOLOGY INC | COMM | 156944100 | $147.84 M | 7 % | 3,670,206 | ||
COGT COGENT BIOSCIENCES INC | COMM | 19240Q201 | $97.62 M | 5 % | 6,798,162 | ||
AMLX AMYLYX PHARMACEUTICALS INC | COMM | 03237H101 | $84.85 M | 4 % | 6,243,812 | ||
CNTA CENTESSA PHARMACEUTICALS PLC | ADRS | 152309100 | $76.06 M | 4 % | 3,136,480 | ||
TNGX TANGO THERAPEUTICS INC | COMM | 87583X109 | $71.70 M | 4 % | 8,536,196 | ||
OCUL OCULAR THERAPEUTIX INC | COMM | 67576A100 | $71.51 M | 4 % | 6,117,232 | ||
DNTH DIANTHUS THERAPEUTICS INC | COMM | 252828108 | $65.98 M | 3 % | 1,676,624 | ||
TOURMALINE BIO INC | COMM | 89157D105 | $62.74 M | 3 % | 1,311,783 | ||
DYN DYNE THERAPEUTICS INC | COMM | 26818M108 | $58.38 M | 3 % | 4,615,144 |
Rows Per Page
10
- 10
- 50
- 100